BRIEF published on 07/30/2026 at 15:43, 3 days 7 hours ago Sanofi Releases Half-Year Financial Report for 2026 AMF Financial Report SEC Sanofi 2026
PRESS RELEASE published on 07/30/2026 at 15:38, 3 days 7 hours ago Press Release: Sanofi’s half-year financial report for 2026 Sanofi announces availability of its half-year financial report for 2026, now accessible on www.sanofi.com, filed with AMF and submitted to SEC Investors Financial Report Sanofi Half-year 2026
BRIEF published on 07/10/2026 at 18:35, 23 days 4 hours ago Sanofi Reports Share and Voting Rights Information for June 2026 Voting Rights French Commercial Code Issued Shares Financial Regulations Sanofi
BRIEF published on 07/10/2026 at 18:35, 23 days 4 hours ago Sanofi: Update on voting rights and shares in June 2026 Voting Rights Investors Actions Sanofi June 2026
PRESS RELEASE published on 07/10/2026 at 18:30, 23 days 4 hours ago Sanofi: Information concerning the total number of voting rights and shares - June 2026 Sanofi discloses total voting rights and shares as per French Commercial Code and AMF regulations for June 30, 2026 Voting Rights French Commercial Code Shares AMF Regulations Sanofi
BRIEF published on 07/01/2026 at 07:35, 1 month 1 day ago Sanofi Releases Aide-Mémoire for Q2 2026 Financial Results Investors Transparency Sanofi Financial Modeling Q2 2026 Results
PRESS RELEASE published on 07/01/2026 at 07:30, 1 month 1 day ago Press Release: Availability of the aide-mémoire for Q2 2026 results Sanofi announced availability of the Q2 2026 results aide-mémoire for financial modelling, covering non-comparable items and share count, to be published on July 30, 2026 Investors Sanofi Aide-mémoire Financial Modelling Q2 2026 Results
BRIEF published on 06/23/2026 at 07:20, 1 month 9 days ago Wayrilz's Approval for the TPI in Japan Sanofi Japan Approval BTK Inhibitor Wayrilz Thrombocytopenia
PRESS RELEASE published on 06/23/2026 at 07:15, 1 month 9 days ago Press Release: Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia Sanofi's Wayrilz (rilzabrutinib) approved in Japan for treating immune thrombocytopenia. Approval based on LUNA 3 study demonstrating platelet response and symptom improvements Japan Sanofi ITP Wayrilz Immune Thrombocytopenia
BRIEF published on 06/23/2026 at 07:05, 1 month 9 days ago Sanofi's Cenrifki Approved in EU for Non-Relapsing SPMS Approval Sanofi HERCULES Study SPMS Cenrifki
Published on 08/01/2026 at 01:20, 1 day 21 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 21 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 22 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 1 day 23 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/02/2026 at 08:15, 14 hours 58 minutes ago Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 1 day 6 hours ago HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 2 days 3 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 2 days 4 hours ago Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 21:00, 2 days 2 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:13, 2 days 3 hours ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 2 days 4 hours ago Covivio Hotels - 2026 Half-year financial report
